5^th World Congress on Advanced Clinical Trials and Clinical Research May 14-15, 2018 Singapore

Dr. Vani Nilakantan is the Vice President, Research at Allina Health System, Minneapolis Minnesota. Dr. Nilakantan has over 25 years research experience in academic and hospital based settings. At Allina Health, she is the head of research for the health system, provides executive level leadership for clinical and basic research within an integrated hospital system environment and is the authorized organizational representative and signatory for system. Dr. Nilakantan Provides visionary perspective on the future of research at a major health care institution. She also sets strategic direction for research and reorganized research structure for Allina Health System. Prior to joining Allina, Dr. Nilakantan was the Director of Investigator Initiated Research and Sponsored Programs Office at Aurora Health Care. At Aurora Health Care, she had oversight of basic science, pre-clinical, translational and clinical research, innovation in alignment with Aurora Health Care mission and strategic priorities. She also created effective collaborative relationships with senior administrative leadership and clinical system program leaders and medical staff. Her responsibilities included oversight of the grants management for the system.

Dr. Vani Nilakantan completed her PhD in Toxicology from the University of Kentucky in 1997. She was a researcher/faculty member at the Medical College of Wisconsin (MCW) until 2010. At MCW, her research focused on oxidative stress in acute kidney injury and cardiac/kidney transplantation. She further continued her research on acute kidney injury at Aurora Health Care, where she worked with data scientists to develop a predictive model for early diagnosis of acute kidney injury She has over 50 abstracts/presentations and over 30 peer-reviewed manuscripts and has been funded through internal foundations, the American Heart Association and the National Institutes of Health.

Gautam Sethi, is a prolific Academician and Researcher currently serving as Associate Professor at Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore. He has completed his postdoctoral training at University of Texas MD Anderson Cancer Center. The focus of his research over the past few years has been to elucidate the mechanism(s) of activation of oncogenic transcription factors such as NF KB/STAT3 by carcinogens and inflammatory agents and the identification of novel inhibitors of these proteins for prevention of and therapy for cancer. The novel findings of his research till date has resulted in 150+ research papers in high impact Scientific Journals and some various prestigious International Awards.

Oncology, Pharmacology

PJ Chen currently is President, United Biopharma (UBP) China responsible for overall development strategy of UBP pipeline and business operation. Previously PJ severed as VP, global clinical development at Unite Neuroscience. Prior to that, PJ was executive director at PPD as area head for North Asia clinical management. In this role, he provided overall business support for clinical management group in China, Hong Kong, Korea and Taiwan. After completion of his graduate training at MIT, PJ worked at MGH/HMS/MIT Martinos Center for Biomedical Imaging in Boston. PJ was actively involved in biomarker/MR imaging research with particular focus on oncology clinical research. After years of working in Boston, PJ returned to Asia and have worked with CRO and Pharma companies with increasing responsibilities. In addition to CRO project management and business development experiences, PJ was Respiratory & GI portfolio development lead responsible for successful value delivery of new drugs in China at AstraZeneca and developed comprehensive knowledge for the drug development environment in APAC.

Clinical Research

Dr. Myat Thu Thu Win was graduated M.B.,B.S in 2001 and Master of Medical Science (Pharmacology) in 2005 from Institute of Medicine I, Yangon. She got Japanese government (MEXT) scholarship from 2009-2013. She finished her Ph.D in 2013 from Kanazawa University Graduate School of Medical Science and postdoctoral fellow in the same department for 3 months. She had more than 8 years of teaching and clinical experience as well as 6 years of research experience. She published research and review papers. She is now doing as a senior lecturer Pharmacologist in the Faculty of Medicine, Asian Institute of Medicine Science and Technology (AIMST) University. She got ‘Outstanding award in Medical Science’ from Venus International Foundation and ‘2000 Outstanding Intellectuals of the 21st Century award’ in 2017. She also involved as invited speaker in Contemporary Academic Meet, Chennai, India as well as in International Conference on Toxicology and Clinical Pharmacology, Rome, Italy in 2017.

Clinical Trials, Toxicology

Bharat Bhushan is a Ohio Eminent Scholar and The Howard D. Winbigler Professor and Director of Nanoprobe Lab for Bio- & Nanotechnology and Biomimetics, Dept. of Mechanical and Aerospace Eng., and Graduate Res. Faculty Advisor, Dept. of Mater. Sci.and Eng., Affiliated Faculty, Battelle Center for Science & Technology Policy, John College of Public Affairs, Ohio State University.

Fundamental studies in the interdisciplinary areas of bio/nanotribology/nanomechanics and nanomaterials characterization in bio/nanotechnology and biomimetics with a focus on scanning probe techniques. EDUCATION

Dr. Sadiyo Siad - Born out in the horn of Africa, she fled to Denmark as a refuge and later moved to the UK for her studies. She is a medical multi-specialist, lecturer, consultant, entrepreneur and philanthropist. Her Medical education includes a PhD in Tuberculosis and Immunology, Master’s Degree in Infectious Diseases and Immunology, another Master Degree in Medical Diagnostics, a PGD in Medical Pathology and also finished Honors in an Undergraduate Degree at the University of Leicester and Cranfield University, and a Diploma in Nursing from her early work as a nurse and midwife assistant. Currently, she is serving as a lecturer in infectious diseases and Immunology and is also a Chancellor at Hano Academy.

Infectious Diseases, Immunology, Preventive Medicine, Healthcare System

Dr. Bickkie Nguyen is currently the Vice President of Pharmacy at Apria Healthcare. She is concurrently a Clinical Assistant Professor of Pharmacy Practice and Administration at Western University of Health Sciences and University of Southern California. She is also the CEO/Founder/Consultant Pharmacist/Leadership Coach at Ivy League Healthcare Management LLC. Dr Nguyen was previously the Director of Pharmacy at University Hospital and Medical Center (Florida), Promise Hospital of East Los Angeles and Suburban Medical Center (California), Western Arizona Regional Medical Center (Arizona) and Cardinal Health, Inc (Virginia). She is experienced in both inpatient (small, medium, large, level 1 trauma academic, long term acute care) and outpatient settings and home infusion. Her consulting specialty and experiences is in turnaround pharmacy management, business strategies development, pharmacy operations, personnel management, regulatory compliances, sterile compounding and drug purchasing/distribution best practices. She currently holds clear and active Registered Pharmacist licenses in 8 US states and is on the editorial board of multiple pharmacy journals.

Turnaround pharmacy management, Business strategies development, Pharmacy operations, Personnel management, Regulatory compliances

Michael Coyle, Founder & Principal at VivoScientia, is one of the reputed Medical researchers, Entrepreneur. He finished his B.S. in Biology from Butler University and later went on to pursue M.S in Motor Control and PhD in Human performance from Indiana University. After completion of Doctoral research he carried out a Post-doctoral research in Respiratory Physiology in 2006 at Harvard T.H. Chan School of Public Health. Before setting VivoScientia, previously he has been associated with VivoMetrics as VP, Clinical Development, Director at Culver Academies, Interim CEO at Safe Responder. He also has experience as an Academician at Indiana University. In the year 2009 Michael started his venture VivoScientia and he has been carrying a great amount of work with his Organization till date. He possesses an exceptional ability to communicate complex medical concepts, methods and results.

Clinical Trials and Clinical Development

An experienced pediatrician with intuitive and comprehensive medical communicating skills. Being on both sides of the table- pharmaceutical/biotech and healthcare professionals/hospitals, Namrata understands and comprehends the requirement and delivers spot on. Her forte initiates from being a part of the initial planning to delivering the final customized solutions. She has experience and expertise across all major medical documents (publication, regulatory and marketing) and all major therapeutics areas. As an entrepreneur and trainer, she is always ready to explore new ideas and opportunities which will impact the way scientific evidence is communicated. Turacoz Skill Development Program, a wing of Turacoz Healthcare Solutions, takes initiatives to full fil the gap between the academic curriculum and the industry requirements and have customized and specialized training solutions in the form of seminars, workshops, and e-learning modules for healthcare and pharmaceutical professional, pharmacy students, researchers and scholars. In total, Dr. Namrata has experience of more than 50 trainings, workshops and seminars to educate industry people.

Healthcare, Clinical Research

Dr. Allen Lai is now the senior vice president of ACT Genomics Singapore, strategizing corporate development, planning and execution of cancer genomics clinical & research projects in Southeast Asia. He holds several high key profile roles as Advisor Board of ISPOR Asia Consortium, President of ISPOR Singapore and concurrently Senior Consultant, Ministry of Health and Social Welfare, Taiwan. He received his Ph.D. and MPA, from Lee Kuan Yew School of Public Policy, National University of Singapore, M.Sc. (Preventive Medicine) from National Taiwan University and M.D. from Chung Shan Medical Dental University, Taiwan. He was the principal consultant at IMS Health Asia, and the director of Institute of Health Economics & Management and the academic director of MSc Management of Health Industries in ESSEC Business School.

Preventive Medicine, Infectious Diseases

Dr. Suriyon Tengyai, Professor at Walailak University,Thailand, has an extensive background in both Research and Academic Pharmacology and Medicinal Chemistry. Having served for more than 10 years in Walailak University he holds immense knowledge and keen interest in Medicinal Chemistry, Pharmaceutical Analysis, Clinical Pharmacokinetics, Chemistry of Natural Products. In past he has published more than 20 papers on Pharmacokinetics and Chemistry of Natural Medicinal products in reputed journals around globe.

Medicinal Chemistry, Pharmaceutical Analysis, Clinical Pharmacokinetics, Chemistry of Natural Products.